Swati G Patel1,2, Dennis J Ahnen1,3, Anita Y Kinney4, Nora Horick5, Dianne M Finkelstein5,6, Deirdre A Hill7, Noralane M Lindor8, Finlay MaCrae9, Jan T Lowery10. 1. Department of Medicine, Division of Gastroenterology & Hepatology, University of Colorado Anschutz Medical Center, Aurora, Colorado, USA. 2. Veterans Administration Medical Center, Denver, Colorado, USA. 3. Gastroenterology of the Rockies, Boulder, Colorado, USA. 4. Department of Internal Medicine, University of New Mexico, Albequerque, New Mexico, USA. 5. Massachusetts General Hospital Biostatistics Center, Boston, Massachusetts, USA. 6. Harvard University, Boston, Massachusetts, USA. 7. Department of Internal Medicine, Division of Epidemiology, University of New Mexico, Albuquerque, New Mexico, USA. 8. Department of Health Science Research, Mayo Clinic, Arizona, USA. 9. Department of Colorectal Medicine and Genetics, The Royal Melbourne Hospital Department of Medicine, University of Melbourne, Victoria, Australia. 10. University of Colorado School of Public Health, Aurora, Colorado, USA.
Abstract
OBJECTIVES: Individuals whose families meet the Amsterdam II clinical criteria for hereditary non-polyposis colorectal cancer are recommended to be referred for genetic counseling and to have colonoscopic screening every 1-2 years. To assess the uptake and knowledge of guideline-based genetic counseling and colonoscopic screening in unaffected members of families who meet Amsterdam II criteria and their treating endoscopists. METHODS: Participants in the Family Health Promotion Project who met the Amsterdam II criteria were surveyed regarding their knowledge of risk-appropriate guidelines for genetic counseling and colonoscopy screening. Endoscopy/pathology reports were obtained from patients screened during the study to determine the follow-up recommendations made by their endoscopists. Survey responses were compared using Fisher's Exact and the χ(2) test. Concordance in participant/provider-reported surveillance interval was assessed using the kappa statistic. RESULTS: Of the 165 participants, the majority (98%) agreed that genetics and family history are important predictors of CRC, and 63% had heard of genetic testing for CRC, although only 31% reported being advised to undergo genetic counseling by their doctor, and only 7% had undergone genetic testing. Only 26% of participants reported that they thought they should have colonoscopy every 1-2 years and 30% of endoscopists for these participants recommended 1-2-year follow-up colonoscopy. There was a 65% concordance (weighted kappa 0.42, 95% CI 0.24-0.61) between endoscopist recommendations and participant reports regarding screening intervals. CONCLUSIONS: A minority of individuals meeting Amsterdam II criteria in this series have had genetic testing and reported accurate knowledge of risk-appropriate screening, and only a small percentage of their endoscopists provided them with the appropriate screening recommendations. There was moderate concordance between endoscopist recommendations and participant knowledge suggesting that future educational interventions need to target both health-care providers and their patients.
OBJECTIVES: Individuals whose families meet the Amsterdam II clinical criteria for hereditary non-polyposis colorectal cancer are recommended to be referred for genetic counseling and to have colonoscopic screening every 1-2 years. To assess the uptake and knowledge of guideline-based genetic counseling and colonoscopic screening in unaffected members of families who meet Amsterdam II criteria and their treating endoscopists. METHODS: Participants in the Family Health Promotion Project who met the Amsterdam II criteria were surveyed regarding their knowledge of risk-appropriate guidelines for genetic counseling and colonoscopy screening. Endoscopy/pathology reports were obtained from patients screened during the study to determine the follow-up recommendations made by their endoscopists. Survey responses were compared using Fisher's Exact and the χ(2) test. Concordance in participant/provider-reported surveillance interval was assessed using the kappa statistic. RESULTS: Of the 165 participants, the majority (98%) agreed that genetics and family history are important predictors of CRC, and 63% had heard of genetic testing for CRC, although only 31% reported being advised to undergo genetic counseling by their doctor, and only 7% had undergone genetic testing. Only 26% of participants reported that they thought they should have colonoscopy every 1-2 years and 30% of endoscopists for these participants recommended 1-2-year follow-up colonoscopy. There was a 65% concordance (weighted kappa 0.42, 95% CI 0.24-0.61) between endoscopist recommendations and participant reports regarding screening intervals. CONCLUSIONS: A minority of individuals meeting Amsterdam II criteria in this series have had genetic testing and reported accurate knowledge of risk-appropriate screening, and only a small percentage of their endoscopists provided them with the appropriate screening recommendations. There was moderate concordance between endoscopist recommendations and participant knowledge suggesting that future educational interventions need to target both health-care providers and their patients.
Authors: David A Lieberman; Douglas K Rex; Sidney J Winawer; Francis M Giardiello; David A Johnson; Theodore R Levin Journal: Gastroenterology Date: 2012-07-03 Impact factor: 22.682
Authors: Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt Journal: Am J Gastroenterol Date: 2015-02-03 Impact factor: 10.864
Authors: Elena M Stoffel; Rowena C Mercado; Wendy Kohlmann; Beth Ford; Shilpa Grover; Peggy Conrad; Amie Blanco; Kristen M Shannon; Mark Powell; Daniel C Chung; Jonathan Terdiman; Stephen B Gruber; Sapna Syngal Journal: Am J Gastroenterol Date: 2010-03-30 Impact factor: 10.864
Authors: Francis M Giardiello; John I Allen; Jennifer E Axilbund; C Richard Boland; Carol A Burke; Randall W Burt; James M Church; Jason A Dominitz; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David A Lieberman; Douglas J Robertson; Sapna Syngal; Douglas K Rex Journal: Gastrointest Endosc Date: 2014-08 Impact factor: 9.427
Authors: Jan T Lowery; Al Marcus; Anita Kinney; Deborah Bowen; Dianne M Finkelstein; Nora Horick; Kathleen Garrett; Robert Haile; Robert Sandler; Dennis J Ahnen Journal: Contemp Clin Trials Date: 2011-11-12 Impact factor: 2.226
Authors: Eveline M A Bleiker; Fred H Menko; Babs G Taal; Irma Kluijt; Lidwina D V Wever; Miranda A Gerritsma; Hans F A Vasen; Neil K Aaronson Journal: Gastroenterology Date: 2005-02 Impact factor: 22.682
Authors: Hoda Anton-Culver; Argyrios Ziogas; Deborah Bowen; Dianne Finkelstein; Constance Griffin; James Hanson; Claudine Isaacs; Carol Kasten-Sportes; Geraldine Mineau; Prakash Nadkarni; Barbara Rimer; Joellen Schildkraut; Louise Strong; Barbara Weber; Deborah Winn; Robert Hiatt; Susan Nayfield Journal: Community Genet Date: 2003
Authors: Brigid Adviento; Michael Conner; Alexander Sarkisian; Nicolette Walano; Hans Andersson; Jordan Karlitz Journal: J Prim Care Community Health Date: 2021 Jan-Dec
Authors: Deborah Cragun; Jason Beckstead; Meagan Farmer; Gillian Hooker; Marleah Dean; Ellen Matloff; Sonya Reid; Ann Tezak; Anne Weidner; Jennifer G Whisenant; Tuya Pal Journal: BMC Cancer Date: 2021-10-13 Impact factor: 4.430
Authors: Jennifer L Schneider; Katrina A B Goddard; Kristin R Muessig; James V Davis; Alan F Rope; Jessica E Hunter; Susan K Peterson; Louise S Acheson; Sapna Syngal; Georgia L Wiesner; Jacob A Reiss Journal: Hered Cancer Clin Pract Date: 2018-05-10 Impact factor: 2.857
Authors: Dayna R Cenin; Steffie K Naber; Iris Lansdorp-Vogelaar; Mark A Jenkins; Daniel D Buchanan; David B Preen; Hooi C Ee; Peter O'Leary Journal: J Gastroenterol Hepatol Date: 2018-05-17 Impact factor: 4.029